000 01815 a2200493 4500
005 20250516041732.0
264 0 _c20120316
008 201203s 0 0 eng d
022 _a1573-7365
024 7 _a10.1007/s11011-011-9246-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWyse, Angela T S
245 0 0 _aBehavioral and neurochemical effects of proline.
_h[electronic resource]
260 _bMetabolic brain disease
_cSep 2011
300 _a159-72 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _a1-Pyrroline-5-Carboxylate Dehydrogenase
_xdeficiency
650 0 4 _aAmino Acid Metabolism, Inborn Errors
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aAntioxidants
_xmetabolism
650 0 4 _aAscorbic Acid
_xtherapeutic use
650 0 4 _aBrain
_xmetabolism
650 0 4 _aBrain Diseases, Metabolic
_xchemically induced
650 0 4 _aCreatine Kinase
_xmetabolism
650 0 4 _aEnergy Metabolism
_xphysiology
650 0 4 _aFree Radicals
_xadverse effects
650 0 4 _aGlycine
_xmetabolism
650 0 4 _aGyrate Atrophy
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMemory Disorders
_xchemically induced
650 0 4 _aMice
650 0 4 _aOxidative Stress
_xphysiology
650 0 4 _aProline
_xadverse effects
650 0 4 _aProline Oxidase
_xdeficiency
650 0 4 _aRats
650 0 4 _aReceptors, Cholinergic
_xmetabolism
650 0 4 _aReceptors, Purinergic
_xmetabolism
650 0 4 _aRenal Tubular Transport, Inborn Errors
_xmetabolism
650 0 4 _aSodium-Potassium-Exchanging ATPase
_xmetabolism
650 0 4 _aVitamin E
_xtherapeutic use
700 1 _aNetto, Carlos Alexandre
773 0 _tMetabolic brain disease
_gvol. 26
_gno. 3
_gp. 159-72
856 4 0 _uhttps://doi.org/10.1007/s11011-011-9246-x
_zAvailable from publisher's website
999 _c20902013
_d20902013